Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

A flow diagram of prospective participants and respondents to the study.

More »

Fig 1 Expand

Table 1.

Demographic information of survey respondents.

More »

Table 1 Expand

Fig 2.

Depressive symptoms, as measured by the PHQ-9, across phases of the pandemic.

Data points refer to mean scores of the given psychosocial measure, error bars refer to the standard error. Pre-COVID: Prior to mid-March 2020; Phase 1: Mid-March 2020 to mid-May 2020; Phase: 2/3: Mid-May 2020 to November 2020; Phase 2/3_2: Mid-May 2020 to August 2020; Phase 4: September 2020 to October 2020; Phase 5: November 2020 to March 1, 2021.

More »

Fig 2 Expand

Fig 3.

Anxiety symptoms, as measured by the GAD-7, across phases of the pandemic.

Data points refer to mean scores of the given psychosocial measure, error bars refer to the standard error. Pre-COVID: Prior to mid-March 2020; Phase 1: Mid-March 2020 to mid-May 2020; Phase: 2/3: Mid-May 2020 to November 2020; Phase 2/3_2: Mid-May 2020 to August 2020; Phase 4: September 2020 to October 2020; Phase 5: November 2020 to March 1, 2021.

More »

Fig 3 Expand

Fig 4.

Pandemic stress symptoms, as measured by the CoRonavIruS Health Impact Survey (CRISIS), across phases of the pandemic.

Data points refer to mean scores of the given psychosocial measure, error bars refer to the standard error. Pre-COVID: Prior to mid-March 2020; Phase 1: Mid-March 2020 to mid-May 2020; Phase: 2/3: Mid-May 2020 to November 2020; Phase 2/3_2: Mid-May 2020 to August 2020; Phase 4: September 2020 to October 2020; Phase 5: November 2020 to March 1, 2021.

More »

Fig 4 Expand

Fig 5.

Loneliness symptoms across phases of the pandemic.

Data points refer to mean scores of the given psychosocial measure, error bars refer to the standard error. Pre-COVID: Prior to mid-March 2020; Phase 1: Mid-March 2020 to mid-May 2020; Phase: 2/3: Mid-May 2020 to November 2020; Phase 2/3_2: Mid-May 2020 to August 2020; Phase 4: September 2020 to October 2020; Phase 5: November 2020 to March 1, 2021.

More »

Fig 5 Expand

Table 2.

Impact of sociodemographic factors and pandemic phase on psychosocial outcomes.

More »

Table 2 Expand

Table 3.

Changes in alcohol and cannabis use across sociodemographic factors.

More »

Table 3 Expand

Table 4.

Psychosocial outcomes and sociodemographic factors for those that reported an increase in alcohol use.

More »

Table 4 Expand

Fig 6.

Cannabis use across different genders.

More »

Fig 6 Expand

Table 5.

Psychosocial outcomes and sociodemographic factors for those that reported an increase in cannabis.

More »

Table 5 Expand